Fulminant type 1 diabetes caused by dual immune checkpoint blockade in metastatic renal cell carcinoma

Ann Oncol. 2017 Jan 1;28(1):191-192. doi: 10.1093/annonc/mdw447.

G H Teló¹, G F Carvalhal², C G S Cauduro², V S Webber³, C H Barrios^{2

3

4

5}, A P Fay^{2

3

4

5}

¹ Endocrinology Department, Federal University of Rio Grande do Sul (UFRGS), Porto Alegre.
² School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul 90619-900, Brazil.
³ Clinical Research Center, PUCRS, Porto Alegre, Brazil.
⁴ Medical Oncology, Hospital do Câncer Mãe de Deus, Porto Alegre, Brazil.
⁵ Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.

No abstract available

Publication types